CP and breast carcinoma: On the basis of the results obtained in network pharmacology, therapeutic effect of CP was investigated by western blotting, signifying that EAFCP treatment could regulates ER signaling pathway and suggesting that breast cancer can be treated through a complex system with multi-component target disease interaction.